You have read all your free articles, to continue reading subscribe to read the rest of this content.
Since launching at Davos in 2017, an Oslo-based global organization has been accelerating pandemic preparations.
Years before COVID-19 appeared, the Coalition for Epidemic Preparedness Innovations (CEPI) began working to make vaccine development – including for coronaviruses – faster and less
Related Posts
Valneva SE has announced the initiation of a Phase 1/2 clinical study for its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001. VLA2001 leverages the manufacturing platform of Valneva’s licensed Japanese encephalitis vaccine, IXIARO and is the first publicly announced inactivated vacAlready a subscriber Login You have read all your free articles,…
Professor Trine Hyrup Mogensen from Aarhus University will study why some people suffer from serious COVID-19 infections, while others do not become ill at all, even when exposed to massive infection. Hyrup Mogensen, who is a professor at the Department of Biomedicine and a medical doctor at the Already a…
The new antibody test has been developed from scratch in close collaboration between Rigshospitalet, the University of Copenhagen and Novo Nordisk A/S, with support from the Carlsberg Foundation and the Novo Nordisk Foundation. The test can make a major contribution to monitoring the transmissionAlready a subscriber Login You have read…
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has provided authorisation for emergency supply of COVID-19 Vaccine AstraZeneca, formerly AZD1222, for the active immunisation of individuals 18 years or older. The authorisation recommends two doses administered with an interval Already a subscriber Login You have read all your free articles,…